Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: Efficacy and toxicity in breast cancer xenografts

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 8, 1997, Pages 4000-4004

  Denardo, Sally J ^a,d   Kukis, David L ^a   Kroger, Linda A ^a   O'Donnell, Robert T ^a,b   Lamborn, Kathleen R ^b   Miers, Laird A ^a   Denardo, David G ^a   Meares, Claude F ^c   Denardo, Gerald L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

antibody; breast carcinoma

Indexed keywords

CHIMERIC ANTIBODY; PACLITAXEL; PROTEIN P53; YTTRIUM 90;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; XENOGRAFT;

ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTERLEUKIN-6; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PACLITAXEL; RADIOIMMUNOTHERAPY; TRANSPLANTATION, HETEROLOGOUS; YTTRIUM RADIOISOTOPES;

ANIMALIA;

EID: 0030933299     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.8.4000     Document Type: Article

References (35)

1. Levine, A. J., Momand, J. & Finlay, C. A. (1991) Nature (London) 351, 453-456.
2. Harris, C. C. (1996) J. Natl. Cancer Inst. 88, 1442-1455.
3. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. (1991) Science 253, 49-53.
4. Lane, D. P. (1992) Nature (London) 358, 15-16.
5. Leek, R. D., Kaklamanis, L., Pezzella, F., Gatter, K. C. & Harris, A. L. (1994) Br. J. Cancer 69, 135-139.
6. Parker, S. L., Tong, T., Bolden, S. & Wingo, P. A. (1996) CA-Cancer J. Clin. 65, 5-27.
7. Wilder, R. B., DeNardo, G. L. & DeNardo, S. J. (1996) J. Clin. Oncol. 14, 1383-1400.
8. DeNardo, S. J., O'Grady, L. F., Macey, D. J., Kroger, L. A., DeNardo, G. L., Lamborn, K. R., Levy, N. B., Mills, S. L., Hellström, I. & Hellström, K. E. (1991) Nucl. Med. Biol. 18, 621-631.
9. DeNardo, S. J., Mirick, G. R., Kroger, L. A., O'Grady, L. F., Erickson, K. L., Yuan, A., Lamborn, K. R., Hellström, I., Hellström, K. E. & DeNardo, G. L. (1994) Cancer 73, 1023-1032.
10. DeNardo, S. J., O'Grady, L. F., Richman, C. M. & DeNardo, G. L. (1994) in Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment, ed. Ceriani, R. L. (Plenum, New York), pp. 203-211.
11. DeNardo, S. J., Zhong, G.-R., Salako, Q., Li, M., DeNardo, G. L. & Meares, C. F. (1995) J. Nucl. Med. 36, 829-836.
12. DeNardo, S. J., Gumerlock, P. H., Winthrop, M. D., Mack, P. C., Chi, S. G., Lamborn, K. R., Shen, S., Miers, L. A., deVere White, R. W. & DeNardo, G. L. (1995) Cancer Res. 55, 5837-5841.
13. Strasser, A., Harris, A. W., Jacks, T. & Cory, S. (1994) Cell 79, 329-339.
14. Wahl, A. F., Donaldson, K. L., Fairchild, C., Lee, F. Y. F., Foster, S. A., Demers, G. W. & Galloway, D. A. (1996) Nat. Med. 2, 72-79.
15. Vogelstein, G. (1990) Nature (London) 348, 681-682.
16. Horwitz, S. B. (1992) Trends Pharmacol. Sci. 13, 134-136.
17. Hadler, S., Chintapalli, J. & Croce, C. M. (1996) Cancer Res. 56, 1253-1255.
18. Liu, A. Y., Robinson, R. R., Hellström, K. E., Murray, E. D., Chang, C. P. & Hellström, I. (1987) Proc. Natl. Acad. Sci. USA 84, 3439-3443.
19. Hellström, I., Horn, D., Linsley, P., Brown, J. P., Brankovan, V. & Hellström, K. E. (1986) Cancer Res. 46, 3917-3923.
20. Marken, J. S., Bajorath, J., Edwards, C. P., Farr, A. G., Schieven, G. L. Hellström, I., Hellström, K. E. & Aruffo, A. (1994) J. Biol. Chem. 269, 7397-7401.
21. Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H. & Skipper, H. E. (1966) Cancer Chemother. Rep. 50, 219-244.
22. Hortobagyi, G. N. & Holmes, F. A. (1996) Semin. Oncol. 23, 4-9.
23. Mattes, M. J., Major, P. P., Goldenberg, D. M., Dion, A. S., Hunter, R. V. P. & Klein, K. M. (1990) Cancer Res. 50, 880-884.
24. Winthrop, M. D., DeNardo, S. J., Muenzer, J. T., Chi, S. G. & Gumerlock, P. H. (1997) Cancer, in press.
25. Li, A., Meares, C. F., Salako, Q., Kukis, D. L., Zhong, G.-R., Miers, L. A. & DeNardo, S. J. (1995) Cancer Res. 55, 5726s-5728s.
26. DeNardo, G. L., Kukis, D. L., Shen, S., Mausner, L. F., Meares, C. F., Srivastava, S. C., Miers, L. A. & DeNardo, S. J. (1996) Clin. Cancer Res., 3, 71-79.
27. Seiverd, C. (1972) Hematology for Medical Technologists, (Lea Febiger, Philadelphia), 4th Ed., pp. 91-432.
28. Agresti, A. (1990) Categorical Data Analysis (Wiley, New York), pp. 283-287.
29. Agresti, A. (1990) Categorical Data Analysis (Wiley, New York), p. 60.
30. Carter, W. H., Jr., & Wampler, G. L. (1986) Cancer Treat. Rep. 70, 133-140.
31. Berenbaum, M. C. (1990) Br. J. Cancer 61, 101-109.
32. Howell, L. P., DeNardo, S. J., Levy, N. B., Lund, J. & DeNardo, G. L. (1995) Int. J. Biol. Markers 10, 129-135.
33. Liebmann, J., Cook, J. A., Fisher, J., Teague, D. & Mitchell, J. B. (1994) Int. J. Radiat. Oncol. Biol. Phys. 29, 559-564.
34. Minarik, L. & Hall, E. J. (1994) Radiother. Oncol. 32, 124-128.
35. Balakrishna, L. L., Ferrell, S. M. & Block, N. L. (1995) Anticancer Res. 15, 93-98.